Cite
Rytkin E, Bure IV, Bochkov PO, et al. MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring. Drug Metab Pers Ther. 2021;doi: 10.1515/dmdi-2021-0118.
Rytkin, E., Bure, I. V., Bochkov, P. O., Akmalova, K. A., Mirzaev, K. B., Cherniaeva, M. S., Ostroumova, O. D., Smirnov, V. V., Grishina, E. A., Saribekian, A. G., Sychev, I. N., & Sychev, D. A. (2021). MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring. Drug metabolism and personalized therapy, . https://doi.org/10.1515/dmdi-2021-0118
Rytkin, Eric, et al. "MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring." Drug metabolism and personalized therapy vol. (2021). doi: https://doi.org/10.1515/dmdi-2021-0118
Rytkin E, Bure IV, Bochkov PO, Akmalova KA, Mirzaev KB, Cherniaeva MS, Ostroumova OD, Smirnov VV, Grishina EA, Saribekian AG, Sychev IN, Sychev DA. MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring. Drug Metab Pers Ther. 2021 Aug 13; doi: 10.1515/dmdi-2021-0118. Epub 2021 Aug 13. PMID: 34390638.
Copy
Download .nbib